Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
JCSE01 - Joint IASLC-CSCO-CAALC Session
- 07:00 - 11:15
- 9/07/2019
- Location: Toronto (1985)
- IASLC CME Accredited
- Type: Joint IASLC-CSCO-CAALC Session
- Track:
- Moderators:Chunxue Bai, Tony Mok, Yi-Long Wu, Qing Zhou, Nan Wu
-
+
JCSE01.06 - New Era Beyond PD-1/PD-L1
08:50 - 09:10 | Presenter: Luis Paz-Ares
- Abstract
Loading...
-
+
IS02 - Symposium by Ology Medical Education: Spotlight On Emerging Immunotherapy Approaches And MET Inhibitors In Advanced NSCLC (Not IASLC CME Accredited)
- 11:30 - 13:00
- 9/07/2019
- Location: Hilton Head (1978)
- Type: Industry Symposia & Workshops
- Track:
-
+
OA02 - A New Vision of Targets and Strategies
- 10:30 - 12:00
- 9/08/2019
- Location: Seoul (2007)
- IASLC CME Accredited
- Type: Oral Session
- Track: Targeted Therapy
- Moderators:Frank Griesinger, Luis Paz-Ares
-
+
OA02.01 - Alectinib in Previously Treated RET-Rearranged Advanced Non-Small-Cell Lung Cancer: A Phase 1/2 Trial (ALL-RET)
10:30 - 10:40 | Presenter: Noriko Yanagitani | Author(s): Shinji Takeuchi, Toshinori Murayama, Kenichi Yoshimura, Yasuhito Imai, Shizuko Takahara, Takahiro Kawakami, Takashi Seto, Yoshihiro Hattori, Kadoaki Ohashi, Masahiro Morise, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto, Makoto Nishio, Seiji Yano
- Abstract
Loading... -
+
OA02.02 - Phase 1 Study of Safety, Tolerability, PK and Efficacy of AMG 510, a Novel KRAS G12C Inhibitor, Evaluated in NSCLC
10:40 - 10:50 | Presenter: Ramaswamy Govindan | Author(s): Marwan G Fakih, Timothy J Price, Gerald S Falchook, Jayesh Desai, James C Kuo, John H Strickler, John C Krauss, Bob T Li, Crystal S Denlinger, Greg Durm, Jude Ngang, Haby Henary, Gataree Ngarmchamnanrith, Erik Rasmussen, Phuong Khanh Morrow, David S. Hong
- Abstract
Loading... -
+
OA02.03 - The Third Generation EGFR Inhibitor (EGFR-TKI) HS-10296 in Advanced NSCLC Patients with Resistance to First Generation EGFR-TKI
10:50 - 11:00 | Presenter: Shun Lu | Author(s): Qiming Wang, Guojun Zhang, Xiaorong Dong, Cheng-Ta Yang, Yong Song, Gee-Chen Chang, You Lu, Hongming Pan, Chao-Hua Chiu, Zhehai Wang, Jifeng Feng, Jianying Zhou, Xingxiang Xu, Renhua Guo, Jianhua Chen, Haihua Yang, Yuan Chen, Zhuang Yu, Her-Shyong Shiah, Chin-Chou Wang, Nong Yang, Jian Fang, Ping Wang, Kai Wang, Yanping Hu, Jianxing He, Ziping Wang, Jianhua Shi, Shaoshui Chen, Ying Cheng, Wu-Chou Su, Te-Chun Hsia, Jiuwei Cui, yuping Sun, Chih-Hsin Yang
- Abstract
Loading... -
+
OA02.04 - Discussant - OA02.01, OA02.02, OA02.03
11:00 - 11:15 | Presenter: Jon Zugazagoitia
- Abstract
No abstract available for this presentation
-
+
OA02.05 - First-In-Human Phase 1/2 Trial of Anti-AXL Antibody–Drug Conjugate (ADC) Enapotamab Vedotin (EnaV) in Advanced NSCLC
11:15 - 11:25 | Presenter: Suresh S Ramalingam | Author(s): Juanita Lopez, Morten Mau-Sorensen, Fiona Thistlethwaite, Sarina Piha-Paul, Shirish Gadgeel, Yvette Drew, Pasi A Jänne, Aaron S. Mansfield, Guang Chen, Ulf Forssmann, Hrefna Kristin Johannsdottir, Nora Pencheva, Annette Ervin-Haynes, Ignace Vergote
- Abstract
Loading... -
+
OA02.06 - The Sequential Therapy of Crizotinib Followed by Alectinib: Real World Data of 840 Patients with NSCLC Harboring ALK-Rearrangement (WJOG9516L)
11:25 - 11:35 | Presenter: Satomi Watanabe | Author(s): Takeharu Yamanaka, Kentaro Ito, Shinya Sakata, Haruko Daga, Takashi Kijima, Katsuya Hirano, Isamu Okamoto, Atsushi Nakamura, TOSHIYUKI Kozuki, Mikiko Ishihara, Koichi Azuma, Takashi Seto, Toshihide Yokoyama, Yuko Oya, Haruki Kobayashi, Kazumi Nishino, Yoshihiro Hattori, Kazuhiko Nakagawa, Nobuyuki Yamamoto
- Abstract
Loading... -
+
OA02.07 - Phase 3 ALUR Study of Alectinib in Pretreated ALK+ NSCLC: Final Efficacy, Safety and Targeted Genomic Sequencing Analyses
11:35 - 11:45 | Presenter: Juergen Wolf | Author(s): Åslaug Helland, In-Jae Oh, Maria Rita Migliorino, Rafal Dziadziuszko, Javier De Castro Carpeno, Julien Mazieres, Frank Griesinger, Marijana Chlistalla, Andres Cardona, Thorsten Ruf, Kerstin Trunzer, Vlatka Smoljanovic, Silvia Novello
- Abstract
Loading... -
+
OA02.08 - Discussant - OA02.05, OA02.06, OA02.07
11:45 - 12:00 | Presenter: Michael Duruisseaux
- Abstract
No abstract available for this presentation
-
+
OA03 - Systemic Therapies for SCLC: Novel Targets and Patients' Selection
- 13:30 - 15:00
- 9/08/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Oral Session
- Track: Small Cell Lung Cancer/NET
- Moderators:Christine Lee Hann, Makoto Nishio
-
+
OA03.03 - Initial Efficacy and Safety Results of Irinotecan Liposome Injection (nal-IRI) in Patients with Small Cell Lung Cancer
13:50 - 14:00 | Presenter: Luis Paz-Ares | Author(s): David R Spigel, Yuanbin Chen, Maria Jove, Oscar Juan, Patricia Rich, Theresa Hayes, Vanesa Gutiérrez Calderón, Reyes Bernabe, Alejandro Navarro, Afshin Dowlati, Bin Zhang, Yan Moore, Tiffany Wang, Natalya Nazarenko, Santiago Ponce, Paul A Bunn, Jr
- Abstract
Loading...
-
+
OA04 - Immuno Combinations and the Role of TMB
- 15:15 - 16:45
- 9/08/2019
- Location: Copenhagen (1980)
- IASLC CME Accredited
- Type: Oral Session
- Track: Immuno-oncology
- Moderators:Solange Peters, Martin Reck
-
+
OA04.02 - CheckMate 817: First-Line Nivolumab + Ipilimumab in Patients with ECOG PS 2 and Other Special Populations with Advanced NSCLC
15:25 - 15:35 | Presenter: Fabrice Barlesi | Author(s): Clarisse Audigier-Valette, Enriqueta Felip, Tudor-Eliade Ciuleanu, Kevin Jao, Erika Rijavec, Laszlo Urban, Jean-Sébastien Aucoin, Cristina Zannori, Karim Vermaelen, Osvaldo Aren Frontera, Neal Ready, Alessandra Curioni Fontecedro, Helena Linardou, Elena Poddubskaya, Jürgen R. Fischer, Ingrid Iordan, Harry JM Groen, Rathi N Pillai, Sunney Li, Joseph Fiore, Han Chang, Angelic Acevedo, Luis Paz-Ares
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-133 - Randomized Open-Label Study of Bintrafusp Alfa (M7824) vs Pembrolizumab in Patients with PD-L1 Expressing Advanced 1L NSCLC
09:45 - 09:45 | Presenter: Myung-Ju Ahn | Author(s): Fabrice Barlesi, Enriqueta Felip, Edward Garon, Claudio Martin, Tony Mok, Everett E. Vokes, Laureen S. Ojalvo, Andre Koenig, Isabelle Dussault, Luis Paz-Ares
- Abstract
Loading...
-
+
P1.04 - Immuno-oncology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P1.04-28 - COAST: Durvalumab Alone or with Novel Agents for Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Roy S. Herbst | Author(s): Fabrice Barlesi, Luis Paz-Ares, David Raben, Charu Aggarwal, John Bothos, Ramin Samadani, Peng He, Natasha Angra, Pablo Martinez
- Abstract
Loading...
-
+
P1.12 - Small Cell Lung Cancer/NET
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Small Cell Lung Cancer/NET
-
+
P1.12-03 - Antitumor Activity of Single Agent Lurbinectedin in Patients with Relapsed SCLC Occurring ≥30 Days After Last Platinum Dose
09:45 - 09:45 | Presenter: Jose Manuel Trigo Perez | Author(s): Vivek Subbiah, Benjamin Besse, Victor Moreno, Rafael López, M.Angeles Sala, Santiago Ponce, Cristian Fernendez, Antonio Nieto, Carmen Kahatt, Ali Zeaiter, Khalil Zaman, Valentina Boni, Jennifer Arrondeau, Marta Martinez, Jean Pierre Delord, Ahmad Awada, Rebeca Kristeleit, Fede Longo, John Sarantopoulos, Maria Jesús Rubio, Antonio Anton, Luciano Wannesson, Javier Valdivia, Geoffrey Shappiro, Víctor Villalobos, Armando Santoro, Manolo D'Arcangelo, Luis Aparicio, Luis Paz-Ares
- Abstract
Loading...
-
+
PL02 - Presidential Symposium including Top 7 Rated Abstracts
- 08:00 - 10:15
- 9/09/2019
- Location: Barcelona (2005)
- IASLC CME Accredited
- Type: Plenary Session
- Track:
- Moderators:Giorgio Vittorio Scagliotti, Ramon Rami-Porta
-
+
PL02.11 - Overall Survival with Durvalumab Plus Etoposide-Platinum in First-Line Extensive-Stage SCLC: Results from the CASPIAN Study
09:38 - 09:48 | Presenter: Luis Paz-Ares | Author(s): Yuanbin Chen, Niels Reinmuth, Katsuyuki Hotta, Dmytro Trukhin, Galina Statsenko, Maximilian J. Hochmair, Mustafa Özgüroğlu, Jun Ho Ji, Oleksandr Voitko, Artem Poltoratskiy, Santiago Ponce, Francesco Verderame, Libor Havel, Igor Bondarenko, Andrzej Kazarnowicz, György Losonczy, Nikolay V. Conev, Jon Armstrong, Natalie Byrne, Norah Shire, Haiyi Jiang, Jonathan Goldman
- Abstract
Loading...
-
+
PR03 - Press Conference
- 10:15 - 11:00
- 9/09/2019
- Location: CC7.1 A&B
- Type: Press Conference
- Track:
-
+
PR03.08 - Overall Survival with Durvalumab Plus Etoposide-Platinum in First-Line Extensive-Stage SCLC: Results from the CASPIAN Study
10:55 - 11:00
- Abstract
No abstract available for this presentation